[From The committee for the Registration of Adverse Effects. Adverse effects following Eraldin therapy].
D005128:Eye Diseases / Q000139:chemically induced; D006801:Humans; D011217:Practolol / Q000008:administration & dosage / Q000009:adverse effects*; D012871:Skin Diseases / Q000139:chemically induced
D011217:Practolol
Fra bivirkningsnemnda. Bivirkninger ved eraldin-behandling